Search Tufts Medicine

Displaying 21 - 40 of 170
Patient Stories
February 21, 2021
After enjoying a day of golf with his friends, Stanley Coolen began experiencing an upset stomach. Stanley is an active, healthy 72-year old from Saugus, MA. According to him, neither he nor his wife, Nicky, had been sick for a day in the nearly 50 years they had been married. But as he approached the clubhouse, he collapsed in cardiac arrest.
Patient Stories
January 29, 2019
It was April 8, 2018, and Dana Corr was looking forward to celebrating his 55th birthday that day with his wife and two daughters in their Westford home. He had just returned from a trip visiting colleges in Rhode Island the day before with his daughter. Unfortunately, all celebrations were put on hold that day as his heart seemed to have other plans.
clinical trial
...

The primary goal of this study is to improve our understanding of changes in skeletal muscle mass in the arms and the legs during a hospitalization for advanced HF. We plan to measure muscle thickness with an ultrasound machine in two locations on the body (the outer thigh and the upper arm muscle, of the dominant side) from the time a patient is first admitted to the ICU with HF as well as before and after any surgical HF therapies.
clinical trial
...

Heart failure is a harmful disease that is associated with high avoidable moribidity that can be treated with a cardiac resynchronization therapy device (CRT-D). Previous studies have shown links between CRT-D implants and reduced rates of morbidity in patients with heart failure with left bundle branch blockages (LBBB). However, there is limited amounts of evidence for the success of heart failure patients with non-LBBB. This prospective, multi-center study is looking at heart failure patients with non-LBBB that are implanted with CRT-D. 
Patient Stories
January 30, 2020
Mac and his team at Tufts MC refused to let cardiomyopathy take his life, so they did all they could to get him to a heart transplant.
clinical trial
...

The purpose of this randomized study is to evaluate the safety and effectiveness of EVAHEART 2 Implantable Left Ventricular Assist System (EVA2 LVAS) by demonstrating non-inferiority to HeartMate 3 when used for the treatment of advanced, refractory, New York Heart Association Class IV heart failure.
Articles
February 18, 2021
February is Heart Health Month, a month that encourages everyone to evaluate what they can do to improve their heart health.
Patient Stories
June 19, 2019
For years, Jeff, an active man in his early 40s and an intensive care unit (ICU) nurse at a hospital in New Bedford, couldn’t understand why he felt so tired. Neither could his medical doctors. He received various diagnoses, with no improvement in his symptoms.